Omnicell, Inc.

Omnicell provides medication management solutions and adherence tools for healthcare systems and pharmacies worldwide. They offer point-of-care automation, automated dispensing systems, robotic dispensing, central pharmacy automation, IV compounding robots, and inventory management software. The company also provides single-dose automation, filling equipment, packaging supplies, and EnlivenHealth Patient Engagement web-based solutions.

Overview

Sector

Health Information Services

Target Price

139.7 USD

Current Price

31.2 USD

Potential

83%

Strengths

Price to book ratio (1.14) is lower than the sector mean (2.07).
The company has low debt. Net Debt to EBITDA Ratio is 0.15 and it is lower than the sector mean.
Price to free cash flow (10.53) is lower than the sector mean.

Weaknesses

With a depreciation Potential of -100.00%, based on our fundamental analysis, it suggests the stock may be overvalued.
EV/EBIT (4257.24) is significantly higher than the sector mean.
EBITDA Margin (8.10%) appears relatively low.

Key Financial Data

Indicator	Value
PER	10.1
EV/EBITDA	6.4
Price/Free Cash Flow'	9.4
ROIC	16.9%
Net Debt/EBITDA	0.7